Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Many mechanisms have been proposed to explain why immune responses against human tumor antigens are generally ineffective. For example, tumor cells have been shown to develop active immune evasion mechanisms. Another possibility is that tumor antigens are unable to optimally stimulate tumor-specific...

Podrobná bibliografie
Hlavní autoři:	Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P
Médium:	Journal article
Jazyk:	English
Vydáno:	1999

Podobné jednotky

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Autor: Valmori, D, a další
Vydáno: (1999)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Autor: Valmori, D, a další
Vydáno: (2000)

An antigen-targeted approach to adoptive transfer therapy of cancer.
Autor: Valmori, D, a další
Vydáno: (1999)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
Autor: Romero, P, a další
Vydáno: (1998)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
Autor: Valmori, D, a další
Vydáno: (1999)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
Autor: Pittet, M, a další
Vydáno: (1999)

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
Autor: Speiser, D, a další
Vydáno: (1999)

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
Autor: Speiser, D, a další
Vydáno: (1999)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Autor: Valmori, D, a další
Vydáno: (2000)

Immune monitoring in cancer immunotherapy.
Autor: Romero, P, a další
Vydáno: (2000)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
Autor: Chen, J, a další
Vydáno: (2000)

The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Autor: Hudrisier, D, a další
Vydáno: (1998)

Tumor cell recognition efficiency by T cells.
Autor: Daniel E Speiser, a další
Vydáno: (2005-03-01)

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
Autor: Juliette Desfrançois, a další
Vydáno: (2010-01-01)

Quantitating T cell cross-reactivity for unrelated peptide antigens.
Autor: Ishizuka, J, a další
Vydáno: (2009)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
Autor: Douglas McNeel, a další
Vydáno: (2023-11-01)

Antigen presentation. Naturally processed peptides.
Autor: Elliott, T, a další
Vydáno: (1990)

The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
Autor: Hudrisier, D, a další
Vydáno: (1998)

Antigenic reactivity of peptides derived from wheat gluten with sera from patients with coeliac disease.
Autor: Rawcliffe, P, a další
Vydáno: (1985)

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
Autor: Youde, S, a další
Vydáno: (2000)

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
Autor: Kessler, B, a další
Vydáno: (1997)

Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
Autor: Aleksic, M, a další
Vydáno: (2010)

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
Autor: Danila Valmori, a další
Vydáno: (2004-11-01)

Reactivity of sulfonylbutadienes. Synthesis of Ginsenol analogues
Autor: David Diez, a další
Vydáno: (2010-10-01)

A tumor-binding antibody with cross-reactivity to viral antigens
Autor: Michael J. Campa, a další
Vydáno: (2025-02-01)

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
Autor: Griffiths, E, a další
Vydáno: (1998)

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
Autor: Laura Carretero-Iglesia, a další
Vydáno: (2020-01-01)

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
Autor: Larsson, M, a další
Vydáno: (2000)

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
Autor: André, P, a další
Vydáno: (1998)

Synthesis and reactivity of novel gamma-phosphate modified ATP analogues.
Autor: Lee, SE, a další
Vydáno: (2009)

Synthesis and reactivity of novel γ-phosphate modified ATP analogues
Autor: Lee, SE, a další
Vydáno: (2009)

Synthesis of a novel analogue of peptide ProGlyPro
Autor: A. V. Baranov, a další
Vydáno: (2006-12-01)

Identifying individual T cell receptors of optimal avidity for tumor antigens
Autor: Michaël eHebeisen, a další
Vydáno: (2015-11-01)

IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES
Autor: A. Yu. Artamonov, a další
Vydáno: (2014-07-01)

363 Identification of dark antigen® reactive T cell receptors from tumor-infiltrating lymphocytes
Autor: Özcan Met, a další
Vydáno: (2023-11-01)

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Autor: Kessler, B, a další
Vydáno: (1998)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
Autor: Lahman, MC, a další
Vydáno: (2022)

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
Autor: Wenwen Wang, a další
Vydáno: (2023-03-01)

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
Autor: Smith, D, a další
Vydáno: (2002)

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
Autor: Speiser, D, a další
Vydáno: (1997)